Hold Lupin for long term: Gaurang Shah

Gaurang Shah of Geojit Financial Services told CNBC-TV18, "I don’t think that pharmaceutical is on the way to recovery. For Lupin specifically, with the kind of concerns that are there, I don’t think the resolution is going to come out any time sooner. Our target I think is close to about Rs 1,500-1,600 or thereabout. So you need to average and possibly give it another year and a half to two for you to make a profitable exit."

"I would not tell to sell because I personally feel that both IT and pharmaceutical which is the least preferred sectors, we believe long term growth story is there. So, with one and half to two years perspective you can definitely hold on unless you are in rush to get out of it," he added.